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Fewer than 5% of all patients with end-stage kidney 
disease (ESKD) in sub-Saharan Africa receive dial-
ysis, with patients in several countries having no 
access at all.[1] While the situation is somewhat less 
dire in South Africa (SA), we compare very poorly 
with countries that are our economic peers (Fig. 1). The recent 
release of the South African Renal Registry by the South African 
Renal Society[2] produced data that were so alarming that the 
National Department of Health (NDoH) convened a national summit 
to discuss the challenges faced in SA. Delegates to the summit 
included relevant stakeholders: public and private sector clinicians, 
healthcare funders, representatives of the pharmaceutical industry 
and the NDoH, a representative of the World Health Organization 
(WHO) and representatives of the National Kidney Foundation. The 
meeting was held in Johannesburg over 2 days in March 2015 and 
produced recommendations to provide short-, medium- and long-
term solutions. Discussions revolved around a few key issues in an 
attempt to find workable solutions.
Human resources
Chronic kidney disease (CKD) affects 14% of the adult population 
in sub-Saharan Africa.[1] The vast majority of South Africans who 
have ESKD die because of lack of access to definitive lifesaving treat-
ment.[3] The major challenge faced by the country is lack of sufficient 
resources – capital and human – to provide universal access. The 
reason why SA has lagged so severely behind in the provision of 
renal replacement treatment (RRT) compared with similar middle-
income countries is probably the HIV/AIDS epidemic, which has 
demanded a disproportionate quantum of the health budget.[4] In 
addition, there are inequities in the provision of renal services at 
several levels. Poorer patients and patients in rural areas are under-
served as a result of the lack of facilities. In response to RRT being 
made a minimum prescribed benefit, the private sector facilities have 
grown by over 3  000% over two decades, but in contrast there has 
been no significant growth in renal services in the public sector that 
serves over 80% of the country’s population.[2] The renal community 
faces a major shortage of skilled personnel and reflects the national 
skills challenges.[5]
The lack of appropriate and adequate skilled personnel has hampered 
the development of renal care in SA. Insufficient numbers of personnel 
are being trained and effective retention strategies are lacking. To 
address the situation, the summit proposed medium- and long-term 
strategies. In order to ensure high-quality renal care it was agreed 
that a nephrologist (or a specialist physician where no nephrologist 
is available) should be attached to every dialysis unit. SA currently 
has 1.1 nephrologists per million population (pmp), compared with 
6.5 and 4.5 in Egypt and Morocco, respectively – not even comparing 
ourselves with high-income countries.[6] Additional posts to train 
more specialist nephrologists were strongly recommended. This 
would also require an increase in the number of permanent academic 
hospital posts and a clear retention strategy. A mid-level worker, 
provisionally identified as a ‘clinical associate’ working under the 
supervision of a nephrologist, was proposed as an option. The clinical 
associate would be trained to perform procedures that would obviate 
the need to transfer patients to the care of a nephrologist, including 
insertion of dialysis catheters and performing renal biopsies. The role 
of this associate will need further discussion to ensure that the level of 
training is matched to the requisite skills level.
Renal nurses form the backbone of any renal replacement pro-
gramme, but are in short supply. An important approach is to create 
more training centres and programmes for renal nurses around 
the country. A way of optimising the use of the limited numbers 
of renal nurses is to reduce the recommended dialysis staff-to-
patient ratio from the current 1:4 to 1:6, as a strategy that would 
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be easily and rapidly implemented. While 
this may raise some concerns, these ratios 
do prevail in dialysis units in high-income 
countries.[7] The risks are those of greater 
burnout and reducing the quality of care, 
although there are limited data to support 
this as yet.[8] However, with the current 
gene ration of dialysis machines equipped 
with vastly improved technology and safety 
features, a different level of nursing oversight 
is required. Reducing the staffing ratio may 
allow additional dialysis sessions to be acti-
vated without additional infrastructure. 
However, the summit made the crucial 
sugges tion that a completely different 
staffing model be considered: dialysis units 
should be staffed with registered nurses 
who take responsibility for up to 16 patients 
with the development of a team of mid-
level workers specifically trained to provide 
dialysis-related services who would work 
under the supervision of the registered 
nurse.[9] In this way, staff-to-patient ratios of 
1:4 could be retained but costs contained, as 
fewer registered nurses would be required. 
The summit recommended a staff-to-patient 
ratio for peritoneal dialysis of 1:25.
The summit also recognised that a 
successful renal programme required 
the services of other skilled personnel, 
including surgeons (trained in fashioning 
vascular access and placement of peritoneal 
dialysis catheters) and dialysis technicians 
(whose scope of practice must be broadened 
to assist the registered nurses), alongside 
social workers, dieticians and transplant 
co- ordinators, among other support staff. 
Several of these staff could be shared 
between units in the same region. The shor-
tage of surgeons and limited theatre times 
to perform the relevant procedures is a 
major factor compromising patient care; 
delays in fashioning vascular fistulas mean 
that prolonged temporary vascular access is 
required, resulting in severe morbidity and, 
not infrequently, in preventable deaths.
Dialysis
Dialysis is expensive, and is conserva tively 
estimated to cost approximately ZAR200 000 
per annum per patient. Des pite the fact that 
haemodialysis requires considerably more 
infrastructure and staff, the cost differ-
ential between haemodialysis and peritoneal 
dialysis is minimal and favours haemo-
dialysis as the cheaper op tion.[10] The high 
costs of peritoneal dialysis fluid needs to be 
interrogated, considering that such fluids 
are locally produced and are less expensive 
in countries that use locally sourced prod-
ucts.[10]
The summit proposed short- and long-
term solutions to improve costs. Developing 
the new staffing model alluded to above 
could be an important long-term solution. 
Other measures that could be instituted 
almost immediately include tendering for 
items at a national level to benefit from 
economies of scale, minimising hospital 
admissions and stay, ensuring quality dialysis 
and patient care, and the appropriate use of 
pharmaceuticals. The summit was cognisant 
of the fact that a large proportion of our 
patients are based in rural areas, making 
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Fig. 1. Prevalence rates of dialysis in various countries (pmp) in 2012. The countries are listed in order 
of increasing gross national income per capita (GNI-PC) in 2012. All countries listed above SA are 
categorised as high income by the World Bank. SA and those below are upper-middle countries (lighter 
shade). South Africa’s GNI-PC was USD11 726, compared with USD123 365 and USD6 060 for Qatar 
and the Philippines, respectively. SA has the lowest reported dialysis rate and with few exceptions fares 
considerably poorly compared with countries with comparable GNI-PC. The dialysis rates are from 
the US National Institutes of Health and the US Renal Data System,[21] and GPI-PC data are from the 
Human Development Reports of the United Nations Development Programme.[22]
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ambulatory care difficult. The summit also recommended a ‘peritoneal 
dialysis first’ strategy and infrastructure to support this approach. 
Several countries have instituted incentives to promote peritoneal 
dialysis, including reducing import duties.[10] Greater use of existing 
dialysis facilities, which are generally adequate, was also recommended 
to allow greater numbers of patients access to treatment; this could be 
achieved in an incremental fashion. Since dialysis machines can be 
used as often as required, the cost of disposables and lack of personnel 
are the main limitations to increasing the use of facilities in the public 
sector. Negotiations with the private sector may allow patients access 
to dialysis in regions where state facilities are lacking, without a major 
outlay by government.
Timely referrals of patients with CKD will improve assessment 
of patients, improve preparation for RRT and obviate the need 
for acute dialysis (which, in SA, is arguably how the majority of 
patients present, only to have the diagnosis of CKD confirmed 
subsequently). Late presentations add to costs in several ways: 
prolonged hospitalisation, need for temporary vascular access 
and more intensive dialysis. Besides the significant economic 
impact, late and ultra-late presentations are associated with 
poorer patient outcomes, and are potentially avoidable.[11] The 
ideal of pre-emptive kidney transplantation would reduce costs 
and improve patient outcomes, but remains an elusive goal; 
globally only 5% of CKD patients receive transplants without prior 
dialysis.[12] Although the summit recognised that while healthcare 
funders bear the brunt of the treatment costs, the economic 
and psychosocial costs to the patient and his/her family are not 
insubstantial. The impact of the disease on the patient’s lifestyle 
and ability to seek employment and earn has a direct influence on 
treatment choices and compliance.
Transplantation
There is no shortage of potential organ donors in SA, as a visit to 
any busy trauma unit will confirm – translating these into actual 
donors is where our challenge lies. The current transplant rate of 
4.7 pmp in SA is woefully inadequate to meet needs and below the 
transplant rate of other middle-income countries.[2] The declining 
number of kidney transplants is the result of declining numbers of 
donations from deceased donors. The summit has recommended 
that deceased donation be prioritised. There are several models of 
organ donation, of which the Spanish and Croatian models are the 
most effective at increasing deceased donor transplantation; the 
former has been successfully employed across a diverse range of 
countries. The successful models have in common an integrated 
approach including legislative changes, centralisation of authority, 
employment of transplant co-ordinators responsible for organ 
recovery, reimbursement of donor hospitals and public awareness 
campaigns.[13,14] Although countries with an opt-out system have 25 - 
30% more donations than countries with required consent, in the 
integrated models – that incorporate opt-out systems – the benefits 
are of lesser importance. The yield of organs with the integrated 
models reduces, or may obviate, the need for non-heart-beating and 
extended criteria donors.[13] The current reliance on living donor 
transplants is of some concern, as there is recent evidence that in 
the long term, altruistic kidney donors may suffer some ill health. [15] 
New deceased donor concepts that bear consideration include those 
of reciprocity and prioritisation, where persons who previously 
registered as donors are prioritised should they require a kidney. This 
has led to a dramatically significant increase in donors and transplants 
in Israel.[16] The introduction of the Spanish model in Latin America 
was less successful, with failure ascribed to scarcity of resources 
and, more importantly, the lack of political will.[17] The importance 
of the involvement of our NDoH in ensuring the success of such 
a programme therefore cannot be over-emphasised. Controversy 
surrounds the use of incentives for organ donation. Notably, the 
World Medical Association, the WHO and the Convention on 
Human Rights and Biomedicine all support compensation for 
expenses the living donor may have incurred.[18] The effect of other 
measures that have been suggested to increase organ donation 
appears to be limited.
There is an urgent need to improve access to RRT for patients 
using the public health service in a fair and equitable fashion, and the 
summit’s call for ‘250 and 25 by 2025!’, which alludes to the plan to 
increase dialysis to 250 pmp and kidney transplantation to 25 pmp by 
2025 (from 164 and 4, respectively), needs to become a clarion call!
Reducing the burden of kidney disease
The SA government’s National Development Plan – 2030 emphasises 
prevention of disease, but to a large extent CKD is the end result of 
a much larger health challenge facing our country. Diseases such 
as hypertension, diabetes mellitus, and to a lesser extent infections 
and acute kidney injury lead to CKD. These diseases need to be 
appropriately managed to reduce the risk of the development of 
CKD. Diabetes mellitus will increase by 88% between 2012 and 2030 
in sub-Saharan Africa, and hypertension by 70% between 2008 and 
2025.[19] The diabetes mellitus epidemic is driven by our sedentary 
lifestyle and poor nutritional choices that contribute to one of the 
largest health challenges facing our society – obesity. Almost 70% 
of SA women are overweight or obese; of even greater concern is 
that over 25% of girls are also overweight or obese.[20] Managing 
the lifestyle diseases will ultimately have a beneficial effect on CKD. 
Community-based screening for CKD is not cost-effective, but high-
risk patients – mainly those with diabetes and hypertension – would 
benefit from strategies that reduce the risk of developing, and retard 
progression to, ESKD. Such an initiative could be driven by health 
workers in primary care.
In closing
Each week, the equivalent of two planeloads of SA lives are lost 
because of lack of access to RRT. This appalling situation is steadily 
getting worse. Appeals from clinicians to health authorities for 
greater access to treatment have been met with the usual refrain 
that resources are insufficient – an explanation that is particularly 
disappointing in face of funds being diverted from the national fiscus 
to a range of expenditures that benefit the citizenry not at all.
We are presenting the NDoH with a well-considered and workable 
blueprint for addressing the crisis of CKD and its treatment. As 
patient advocates who have to manage the crisis, we challenge the 
government to work with us to improve care for patients with CKD. 
Every time one of our patients dies, it is an indictment on us all.
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